Merck & Company Inc (MRK)

Receivables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 64,168,000 63,174,000 62,479,000 61,402,000 60,114,000 59,314,000 58,311,000 57,869,000 59,283,000 58,974,000 57,169,000 53,978,000 48,704,000 46,131,000 43,906,000 41,857,000 43,287,000 36,488,000 37,956,000 40,363,000
Receivables US$ in thousands 10,278,000 11,381,000 11,642,000 11,366,000 10,349,000 10,394,000 11,030,000 10,415,000 9,450,000 9,482,000 9,643,000 9,828,000 9,230,000 8,571,000 7,843,000 8,235,000 7,851,000 8,422,000 7,577,000 8,182,000
Receivables turnover 6.24 5.55 5.37 5.40 5.81 5.71 5.29 5.56 6.27 6.22 5.93 5.49 5.28 5.38 5.60 5.08 5.51 4.33 5.01 4.93

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $64,168,000K ÷ $10,278,000K
= 6.24

The receivables turnover ratio for Merck & Company Inc has shown a generally positive trend over the analyzed period, starting at 4.93 on March 31, 2020, and increasing to 6.24 by December 31, 2024. This indicates that the company is collecting its accounts receivable more efficiently over time.

The highest receivables turnover ratio was observed on December 31, 2022, with a value of 6.27, showcasing the company's strong ability to convert its credit sales into cash. Conversely, the lowest turnover ratio during this period was recorded on September 30, 2020, at 4.33, suggesting a slowdown in accounts receivable collection efficiency at that time.

Overall, the upward trend in receivables turnover is a positive indicator of Merck & Company Inc's effectiveness in managing its accounts receivable and converting them into cash, thereby enhancing its liquidity position and potentially reducing bad debts.


See also:

Merck & Company Inc Receivables Turnover (Quarterly Data)